← Leaderboards
Vernon Bruce Carruthers
Johns Hopkins University
$18,903,624
Attributed
$20,230,064
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,230,064 · 13
By mechanism
R01$12,986,369 · 4
T32$3,230,754 · 1
R21$2,605,438 · 6
R33$1,325,753 · 1
R03$81,750 · 1
Top collaborators
- Andrew David White3 shared
- Scott D Larsen2 shared
- Cagri Besirli1 shared
- Martin Christopher Clasby1 shared
- Matthew J O'Meara1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Sean Taylor Prigge$7,817,609
- Isabelle Coppens$12,207,501
- Rebecca L Lamason$5,285,686
- Mandy J Ward$492,551
Others in their field
Top investigators on “Toxoplasma Gondii”
- L David Sibley · Washington University$42,221,391
- John C Boothroyd · Stanford University$21,342,994
- Christopher A Hunter · University Of Pennsylvania$20,595,527
- Michael W White · University Of California Riverside$17,265,886
- Gary E Ward · University Of Vermont & St Agric College$14,197,597
- William J Sullivan Jr · Indiana University Indianapolis$13,937,697
Research focus
Toxoplasma GondiiToxoplasmosisInfectionCellsParasitesToxoplasmaProteinsTissuesBaseMolecularMembraneStructureVacuoleOrganellesIn VitroPathogenesisGeneticPeptide HydrolasesChronicPathogenCystVirulenceInsightMicrobial
Grant awards (63)
Curing chronic Toxoplasma infection with novel and potent protease inhibitors$603,601
R01 · FY2025 · AI · contact PI
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii$443,859
R01 · FY2025 · AI · contact PI
Defining a novel protein network for Toxoplasma repurposing of host ESCRT machinery$226,980
R21 · FY2025 · AI · contact PI
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii$443,859
R01 · FY2024 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$405,715
T32 · FY2024 · AI · contact PI
Defining a novel protein network for Toxoplasma repurposing of host ESCRT machinery$195,000
R21 · FY2024 · AI · contact PI
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii$442,655
R01 · FY2023 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$401,910
T32 · FY2023 · AI · contact PI
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii$442,477
R01 · FY2022 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$382,785
T32 · FY2022 · AI · contact PI
Identifying novel players in Toxoplasma autophagy during chronic infectionâ$234,000
R21 · FY2022 · AI · contact PI
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii$456,477
R01 · FY2021 · AI · contact PI
Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis$423,128
R33 · FY2021 · AI · contact PI
Microneme function in Toxoplasma$390,000
R01 · FY2021 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$371,287
T32 · FY2021 · AI · contact PI
Identifying novel players in Toxoplasma autophagy during chronic infectionâ$195,000
R21 · FY2021 · AI · contact PI
Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis$442,937
R33 · FY2020 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$393,806
T32 · FY2020 · AI · contact PI
Microneme function in Toxoplasma$390,000
R01 · FY2020 · AI · contact PI
ENDOLYSOSOMAL FUNCTION IN CHRONIC TOXOPLASMA INFECTION$360,475
R01 · FY2020 · AI · contact PI
Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis$459,688
R33 · FY2019 · AI · contact PI
Microneme function in Toxoplasma$390,000
R01 · FY2019 · AI · contact PI
ENDOLYSOSOMAL FUNCTION IN CHRONIC TOXOPLASMA INFECTION$360,475
R01 · FY2019 · AI · contact PI
Microneme function in Toxoplasma$389,583
R01 · FY2018 · AI · contact PI
ENDOLYSOSOMAL FUNCTION IN CHRONIC TOXOPLASMA INFECTION$360,475
R01 · FY2018 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$343,893
T32 · FY2018 · AI · contact PI
Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis$227,976
R21 · FY2018 · AI · contact PI
Microneme function in Toxoplasma$378,425
R01 · FY2017 · AI · contact PI
ENDOLYSOSOMAL FUNCTION IN CHRONIC TOXOPLASMA INFECTION$357,420
R01 · FY2017 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$339,317
T32 · FY2017 · AI · contact PI
Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis$193,750
R21 · FY2017 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$5,016
T32 · FY2017 · AI · contact PI
ENDOLYSOSOMAL FUNCTION IN CHRONIC TOXOPLASMA INFECTION$371,170
R01 · FY2016 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$267,420
T32 · FY2016 · AI · contact PI
T. GONDII CHLOROQUINE RESISTANCE TRANSPORTER AND REDOX$232,500
R21 · FY2016 · AI · contact PI
Microneme function in toxoplasma$341,779
R01 · FY2015 · AI · contact PI
Molecular Mechanisms of Microbial Pathogenesis Training Program$319,605
T32 · FY2015 · AI · contact PI
T. GONDII CHLOROQUINE RESISTANCE TRANSPORTER AND REDOX$193,854
R21 · FY2015 · AI · contact PI
Microneme function in toxoplasma$342,165
R01 · FY2014 · AI · contact PI
Toxoplasma endocytosis of host cytoplasm$233,250
R21 · FY2014 · AI · contact PI
Proteolytic modulation of toxoplasma invasion proteins$350,011
R01 · FY2013 · AI · contact PI
Microneme function in toxoplasma$321,981
R01 · FY2013 · AI · contact PI
Toxoplasma endocytosis of host cytoplasm$194,375
R21 · FY2013 · AI · contact PI
Proteolytic modulation of toxoplasma invasion proteins$372,352
R01 · FY2012 · AI · contact PI
Microneme function in toxoplasma$342,882
R01 · FY2012 · AI · contact PI
Proteolytic modulation of toxoplasma invasion proteins$372,352
R01 · FY2011 · AI · contact PI
Microneme function in toxoplasma$342,861
R01 · FY2011 · AI · contact PI
Proteolytic modulation of toxoplasma invasion proteins$376,113
R01 · FY2010 · AI · contact PI
Proteolytic modulation of toxoplasma invasion proteins$379,912
R01 · FY2009 · AI · contact PI
Microneme Function in Toxoplasma$282,430
R01 · FY2009 · AI · contact PI
Microneme Function in Toxoplasma$282,439
R01 · FY2008 · AI · contact PI
Microneme Function in Toxoplasma$287,920
R01 · FY2007 · AI · contact PI
Microneme Function in Toxoplasma$162,508
R01 · FY2006 · AI · contact PI
Microneme Function in Toxoplasma$146,142
R01 · FY2006 · AI · contact PI
Microneme Function in Toxoplasma$277,100
R01 · FY2005 · AI
MICRONEME FUNCTION IN TOXOPLASMA$286,125
R01 · FY2004 · AI
Mediators of Toxoplasma surviral during infection$81,750
R03 · FY2004 · AI
MICRONEME FUNCTION IN TOXOPLASMA$286,125
R01 · FY2003 · AI
Proteomics analysis Toxoplasma gene knockout phenotypes$245,250
R21 · FY2003 · AI
MICRONEME FUNCTION IN TOXOPLASMA$286,125
R01 · FY2002 · AI
Proteomics analysis Toxoplasma gene knockout phenotypes$233,503
R21 · FY2002 · AI
MICRONEME FUNCTION IN TOXOPLASMA$286,125
R01 · FY2001 · AI
MICRONEME FUNCTION IN TOXOPLASMA$279,971
R01 · FY2000 · AI